Inozyme Pharma, a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of abnormal mineralization, entered into a debt financing facility for up to $70 million with K2 HealthVentures (K2HV), a...
view press release
July 27, 2022, 08:00 AM
|
Eloxx Pharmaceuticals entered into a debt facility of up to $30.0 million with Hercules Capital. Eloxx has drawn the initial tranche of $12.5 million and used the proceeds to repay in full amounts outstanding under the Company’s existing debt...
view press release
October 07, 2021, 08:00 AM
|
Xeris Pharmaceutical entered into an amendment to its existing loan and security agreement with Oxford Finance LLC (Oxford) and Silicon Valley Bank (SVB). The amendment allows for extensions of interest-only payments for up to 12 months, subject to...
view press release
May 07, 2021, 08:11 AM
|
A joint venture between Gordon Brothers and New Mill Capital Holdings has acquired three buildings from Hikma Pharmaceuticals in the Eatontown Industrial Park in Eatontown, NJ. The transaction closed on December 17, 2018 and includes a large share of...
view press release
January 03, 2019, 08:00 AM
|
MidCap Business Credit completed an $8 million Revolving Credit Facility for Sovereign Pharmaceuticals, LLC. The facility was used to refinance the company’s existing senior debt and to support the company’s growth plans and working capital...
view press release
January 02, 2019, 09:00 AM
|
Monroe Capital LLC announced an increase in its credit facility to ProPharma Group (ProPharma) to support the acquisition of Xendo Holding B.V. (Xendo). ProPharma is an existing portfolio company of Linden Capital Partners. Based in the Netherlands...
view press release
August 21, 2018, 08:00 AM
|
Capitala Group, a provider of capital to lower and traditional middle market companies, announced that it recently originated a combination of a senior secured debt facility and minority equity totaling $27.3 million to support Cold Bore Capital in...
view press release
July 24, 2018, 07:00 AM
|
Tricida, Inc., a South San Francisco, CA-based late-stage pharmaceutical company, entered into a $100 million venture debt facility with Hercules Capital, Inc.
Tricida drew down $25 million from the venture debt facility at closing. An additional...
view press release
March 06, 2018, 07:00 AM
|
Verastem, Inc., focused on discovering and developing drugs to improve the survival and quality of life of cancer patients, announced its entry into an amendment to its Loan and Security Agreement with Hercules Capital, Inc., increasing its existing...
view press release
January 05, 2018, 07:15 AM
|
Optinose, a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that it has entered into a $100 million debt financing agreement with funds managed by Athyrium Capital Management...
view press release
January 03, 2018, 08:00 AM
|
Midatech, the international specialty pharmaceutical company focused on developing and commercializing products in oncology, announced that it has entered into a four-year senior secured loan agreement with MidCap Financial of up to $15...
view press release
January 02, 2018, 07:00 AM
|
Square 1 Bank, a division of Pacific Western Bank, announced that it has provided a $4 million credit facility to new client Recursion Pharmaceuticals, Inc., a leading pharmaceutical discovery company. Proceeds from the facility will be used to...
view press release
February 08, 2017, 07:22 AM
|